c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1

B Jiménez1, O V Volpert, F Reiher

  • 1Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.

Oncogene
|June 26, 2001
PubMed

Insights

Thrombospondin-1 (TSP-1), an angiogenesis inhibitor, activates c-Jun N-terminal kinases (JNK) via the CD36 receptor. This JNK activation is crucial for TSP-1 to block new blood vessel formation.

Area of Science:

  • Molecular biology
  • Cell biology
  • Biochemistry

Background:

  • Thrombospondin-1 (TSP-1) inhibits angiogenesis by acting on endothelial cells through the CD36 receptor.
  • TSP-1 blocks endothelial cell migration, proliferation, and morphogenesis, and inhibits neovascularization in vivo.

Purpose of the Study:

  • To investigate the molecular mechanisms by which TSP-1 inhibits angiogenesis.
  • To determine the role of mitogen-activated protein kinases (MAPK) and c-Jun N-terminal kinases (JNK) in TSP-1-mediated anti-angiogenic signaling.

Main Methods:

  • Studied the effect of TSP-1 on MAPK and JNK activation in endothelial cells.
  • Utilized CD36 blocking antibodies and TSP-1-derived peptides to assess the role of CD36.
  • Examined corneal neovascularization in JNK-1 deficient mice.

Main Results:

  • TSP-1 did not affect MAPK activation by angiogenesis inducers.
  • TSP-1 rapidly and transiently activated JNK, dependent on CD36 engagement.
  • Inhibition of corneal neovascularization by TSP-1 was significantly reduced in JNK-1 null mice.

Conclusions:

  • TSP-1 inhibits angiogenesis through the activation of JNK, a stress-activated kinase.
  • CD36 is essential for TSP-1-induced JNK activation and subsequent anti-angiogenic effects.
  • JNK plays a critical role in TSP-1's ability to block neovascularization.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...